Sign in to view content

Results from Part 1 of the Phase 2/3 SIGLEC Trial Assessing AVD-104 for Geographic Atrophy: Glyco-immunologic Modulation of Macrophage Activity

Rishi P. Singh, MD

Video
Published 2024

Related

Inhibition of C1q Protects Photoreceptor Synapses in a Light Damage Model and Is a Potential Treatment for Geographic Atrophy
Patrick Dewey Williams, MD
Annual Meeting Talks
2022
Beyond Complement: A Novel FAS Inhibition Approach for Neuroprotection in GA
Vaidehi S. Dedania, MD
Updates from the Field
2024
Visual Acuity and Reading With One Eye Versus Both Eyes Open in Geographic Atrophy and Associations With Patient-Reported Vision-Related Function
Jun Kong, MD, PhD
On Demand Cases, Courses, and Papers
2021

Category: AMD-Non-Neovascular

See more